Fabre-Kramer Pharmaceuticals
== Fabre-Kramer Pharmaceuticals ==
Fabre-Kramer Pharmaceuticals is a privately held pharmaceutical company based in the United States. The company is known for its focus on the development of novel treatments for central nervous system disorders, particularly in the area of depression and anxiety.
History[edit | edit source]
Fabre-Kramer Pharmaceuticals was founded with the mission to develop innovative therapies for unmet medical needs. Over the years, the company has collaborated with various research institutions and pharmaceutical companies to advance its drug development programs.
Research and Development[edit | edit source]
The company's research and development efforts are primarily focused on the central nervous system. Fabre-Kramer Pharmaceuticals has been involved in the development of several antidepressant and anxiolytic medications. The company employs a strategy of identifying promising compounds and advancing them through clinical trials.
Key Products[edit | edit source]
Fabre-Kramer Pharmaceuticals has developed several key products, although many are still in the clinical trial phase. The company is particularly noted for its work on novel antidepressants that aim to offer improved efficacy and reduced side effects compared to existing treatments.
Collaborations[edit | edit source]
Fabre-Kramer Pharmaceuticals has entered into partnerships with other pharmaceutical companies and academic institutions to enhance its research capabilities. These collaborations have been instrumental in advancing the company's drug candidates through various stages of development.
Future Directions[edit | edit source]
The company continues to focus on expanding its pipeline of central nervous system therapies. Fabre-Kramer Pharmaceuticals aims to bring new treatments to market that address significant unmet needs in mental health care.
Related Pages[edit | edit source]
| Fabre-Kramer Pharmaceuticals Resources | |
|---|---|
|
 |
This article is a pharmaceutical-company stub. You can help WikiMD by expanding it!
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
